Table 3. Multivariate analyses for neurological toxicity and for bleomycin-associated pulmonary toxicity.

		P	Hazard Ratio	95% CI
Neurological Toxicity
	ABVD treatment	p<0.001	0.056	0.012–0.258
	≤4 cycles of treatment	0.027	0.045	0.003–0.705
	Female	0.002	0.057	0.009–0.354
	High LDH	0.625	1.458	0.322–6.602
	EBV	0.322	1.913	0.530–6.902
	KRT81 GG	0.021	6.652	1.330–33.262
Pulmonary toxicity
	ABVD treatment	0.008	0.197	0.059–0.651
	≤4 cycles of treatment	0.998	0.000	0.00-.
	Anemia	0.878	0.868	0.143–5.268
	High B-2-microglobulin	0.660	1.446	0.280–7.460
	XPO5 AC	0.004	0.49	0.006–0.376